Status:
In progress
Technology type:
Device
Decision:
Selected
Reason for decision:
Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Description:
An electroencephalogram (EEG) is a recording of brain activity. It is used to support detecting and assessing epilepsy. The test can help identify the type of epilepsy, what may be triggering the seizures and how best to treat the condition. Conducting and interpreting EEGs needs to be done by specially trained clinicians. The test generates large amounts of results data and interpreting this takes time. The specialist capacity available to conduct and interpret EEGs varies in different parts of the country and so the waiting time for a routine EEG can range from weeks to more than 6 months. There is a need for a faster access to EEG. Several AI software to help interpret EEG results are available. These software could assist clinicians interpreting EEGs and help reduce the time to interpret the results. This may enable doing more tests, reduce waiting times for EEG and help reduce the time to diagnosis or a clinical decision.

Provisional Schedule

Scoping workshop:
13 January 2026
Scope published:
27 January 2026

Project Team

Project lead
Catherine Pank

Email enquiries

If you have any queries please email diagnostics@nice.org.uk

Stakeholders

External assessment group
The Newcastle Upon Tyne Hospitals NHS Foundation Trust (NuTH)

Timeline

Key events during the development of the guidance:

Date Update
02 December 2025 Professional and Patient Expert recruitment closes
04 November 2025 In progress. Scoping has started for topic.
04 November 2025 Stakeholder registration opens
04 November 2025 Professional and Patient Expert recruitment starts
09 October 2025 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our early value assessment interim statement.